BDNF and depressive symptom measurement: Interestingly, 26 weeks of daily intake of n-3 PUFFA increased plasma BDNF levels; however, it showed a significant negative correlation between change in BDNF (at baseline and at the end of the study) and the score of the Calgary Depression Scale for Schizophrenia (CDSS) [43].